Reshape and Orbera — Two gastric balloon devices for weight loss

Medical Letter on Drugs and Therapeutics

Volumn 57, Issue 1476, 2015, Pages 122-123

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; BODY MASS; CLINICAL PRACTICE; CLINICAL TRIAL; ENDOSCOPIC SURGERY; GASTRIC BALLOON; GASTROESOPHAGEAL REFLUX; HUMAN; NAUSEA AND VOMITING; NOTE; OROPHARYNX PAIN; OUTCOME ASSESSMENT; RISK ASSESSMENT; STOMACH ULCER; WEIGHT REDUCTION; ANIMAL; CLINICAL TRIAL (TOPIC); EQUIPMENT DESIGN; OBESITY; PROCEDURES; TRENDS; UTILIZATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; GASTRIC BALLOON; HUMANS; OBESITY; WEIGHT LOSS;

EID: 84940520402     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Diet, drugs, and surgery for weight loss. Med Lett Drugs Ther 2015; 57:21.
2. Costs according to the manufacturers.
3. J Ponce et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015; 11:874.